Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mild Whole-Body Hyperthermia Combined With Liposomal Doxorubicin/5-Fluorouracil in Advanced Malignancy
NCT00003135Phase 2Unknown
- Sponsor
- UTHealth Houston
- Start
- Nov 1997
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, doxorubicin in breast cancer, ovarian cancer, endometrial cancer (EC), Cervical Cancer (CC), sponsored by UTHealth Houston. Status: unknown.
02
Drugs
fluorouracildoxorubicin
03
Conditions
breast cancerovarian cancerendometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00003135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003135.